Want to see CCM full AI Analyst Report?
CCM Stock Chart & Stats
$4.80
-$0.04(-0.90%)
At close: 4:00 PM EST
$4.80
-$0.04(-0.90%)
Day’s Range― - ―
52-Week Range$3.18 - $6.98
Previous CloseN/A
Volume954.00
Average Volume (3M)25.64K
Market Cap
$20.67M
Enterprise Value$3.34B
Total Cash (Recent Filing)$297.79M
Total Debt (Recent Filing)$3.63B
Price to Earnings (P/E)―
Beta0.60
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,815,458
10 Day Avg. Volume72,657
30 Day Avg. Volume25,639
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.00853
P/FCF Ratio-0.01
Enterprise Value/Market Cap161.74
Enterprise Value/Revenue5.71
Enterprise Value/Gross Profit82.91
Enterprise Value/Ebitda-27.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
2025 Revenue ReboundThe strong 2025 revenue rebound indicates renewed demand for oncology and related healthcare services. If maintained through sustained patient volumes and equipment utilization, it could provide a foundation for operating improvement.
Reduced Net LossThe materially smaller net loss shows progress from the prior year and suggests that revenue recovery or cost actions are improving results. Continued execution could gradually narrow losses, although profitability is not yet established.
Improving Cash BurnFree cash flow improved substantially year over year, reducing the pace at which the business consumes capital. This is a constructive trend for liquidity, though cash generation remains negative and still requires disciplined investment and financing management.
Bears Say
Highly Leveraged Balance SheetVery high debt combined with negative equity materially restricts financial flexibility and increases refinancing risk. The capital structure may limit investment in oncology capacity and leave the company vulnerable to weaker operations or tighter financing.
Persistent Operating LossesRecurring operating and net losses indicate that the core business has not yet demonstrated a sustainable earnings model. Volatile, including negative, gross profit further suggests pressure from pricing, utilization, or the high cost base.
Consolidation UncertaintyA change in consolidation status could alter reported revenue, earnings, leverage metrics, and the presentation of key healthcare operations. The uncertainty reduces comparability and may complicate assessment of financial performance and group control.
Concord Medical Services News
CCM FAQ
What was Concord Medical Services’s price range in the past 12 months?
Concord Medical Services lowest stock price was $3.18 and its highest was $6.98 in the past 12 months.
What is Concord Medical Services’s market cap?
Concord Medical Services’s market cap is $20.67M.
When is Concord Medical Services’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Concord Medical Services’s earnings last quarter?
Currently, no data Available
Is Concord Medical Services overvalued?
According to Wall Street analysts Concord Medical Services’s price is currently Overvalued.
Does Concord Medical Services pay dividends?
Concord Medical Services pays a Notavailable dividend of $0.99 which represents an annual dividend yield of N/A. See more information on Concord Medical Services dividends here
What is Concord Medical Services’s EPS estimate?
Concord Medical Services’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Concord Medical Services have?
Concord Medical Services has 2,815,458 shares outstanding.
What happened to Concord Medical Services’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Concord Medical Services?
Currently, no hedge funds are holding shares in CCM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Concord Medical Services
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
Technical Analysis
American Shared Hospital Services
―
Joint
―
Cryo-Cell International
―
DocGo
―
P3 Health Partners
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.49% Other Institutional Investors
99.51% Public Companies and
Individual Investors